Cibus Stock

Cibus has developed plant and microbial platforms.

Sign up today and learn more about Cibus Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cibus Stock

Cibus’ breeding technology works without integrating foreign genetic material, thus the resulting organisms are non-transgenic (non-GM). The Company has developed and patented advanced breeding technologies that enable precise, stable, predictable changes to be made in plants and other organisms without integrating foreign genetic material. Cibus has launched its first crop, SU Canola™, in North America and expects to develop non-transgenic traits in every major crop.

Funding History

July 2017$57.0M
June 2018$70.0M


Senior Vice President & Commercial and Business Development

Bradley Castanho


Rory Riggs

Vice President, Finance

Gerard Pilon

Senior Vice President

Sean O'Connor

Vice President, Commercial Development

David Voss

Senior Vice President & Product Development

Jim Radtke

President & CEO

Peter Beetham

Chief Scientific Officer

Greg Gocal

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: